Drug Cos. Behind On Safety Studies, Researchers Say
Drug companies aren't submitting required post-approval studies for their drugs on time and the U.S. Food and Drug Administration isn't being diligent enough in pushing them to do so or taking...To view the full article, register now.
Already a subscriber? Click here to view full article